Advanced search
Search:  

1 - 2 of 2 results found for MDH2. Did you mean: mdm2

  1. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate...

    BACKGROUND: Duchenne muscular dystrophy (DMD) is a fatal disease for which no cure is available. Clinical trials have shown to be largely underpowered due to inter-individual variability and noisy outcome measures. The availability of biomarkers

    http://iris.ucl.ac.uk/iris/publication/1733624/1

  2. Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of...

    Despite the recent progress in the broad-scaled analysis of proteins in body fluids, there is still a lack in protein profiling approaches for biomarkers of rare diseases. Scarcity of samples is the main obstacle hindering attempts to apply

    http://iris.ucl.ac.uk/iris/publication/952403/2

  3. Page: 1